ID   YCC-11
AC   CVCL_9648
SY   YCC11
DR   EFO; EFO_0002878
DR   cancercelllines; CVCL_9648
DR   Cosmic; 1482084
DR   GEO; GSM552380
DR   GEO; GSM562412
DR   GEO; GSM1237683
DR   GEO; GSM1237708
DR   Progenetix; CVCL_9648
DR   Wikidata; Q54995322
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=18804159;
RX   PubMed=18922971;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 38 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
RX   DOI=10.1158/1538-7445.AM2016-139;
RA   Kim T.S., Park K.H., Kwon W.S., Lee W.S., Jeong I., Kang S.K.,
RA   Kim H.M., Rha S.Y., Chung H.C.;
RT   "Novel gastric cancer cell lines established from diffuse type gastric
RT   cancer patients for potential subgroup-specific therapy.";
RL   Cancer Res. 76 Suppl. 14:139-139(2016).
//
RX   PubMed=18804159; DOI=10.1016/j.ygeno.2008.08.002;
RA   Jung J.-J., Jeung H.-C., Chung H.C., Lee J.O., Kim T.S., Kim Y.T.,
RA   Noh S.H., Rha S.Y.;
RT   "In vitro pharmacogenomic database and chemosensitivity predictive
RT   genes in gastric cancer.";
RL   Genomics 93:52-61(2009).
//
RX   PubMed=18922971; DOI=10.1158/1541-7786.MCR-08-0166;
RA   Yu E.J., Lee Y., Rha S.Y., Kim T.S., Chung H.C., Oh B.K., Yang W.I.,
RA   Noh S.H., Jeung H.-C.;
RT   "Angiogenic factor thymidine phosphorylase increases cancer cell
RT   invasion activity in patients with gastric adenocarcinoma.";
RL   Mol. Cancer Res. 6:1554-1566(2008).
//
RX   PubMed=29435981; DOI=10.1002/ijc.31304;
RA   Kim H.J., Kang S.K., Kwon W.S., Kim T.S., Jeong I., Jeung H.-C.,
RA   Kragh M., Horak I.D., Chung H.C., Rha S.Y.;
RT   "Forty-nine gastric cancer cell lines with integrative genomic
RT   profiling for development of c-MET inhibitor.";
RL   Int. J. Cancer 143:151-159(2018).
//